Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

The China-based trial enrolled 398 patients who were randomised to the ivonescimab and Keytruda arms at a one-to-one ratio.

Jefferies analyst Akash Tewari maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...

Barron's market reporter Jacob Sonenshine breaks down the market as the Fed meeting kicks off and spotlights pharmaceutical company Merck.

Evercore ISI analyst Umer Raffat maintained a Buy rating on Organon (OGN – Research Report) today. The company’s shares opened ...

Citi reinstated its coverage of Eli Lilly & Co. (NYSE: LLY) with a Buy rating and a target price of $1,060 per share in a ...

MRK and Daiichi Sankyo's patritumab deruxtecan shows statistically significant progression-free survival improvement in previously treated EGFR-mutated NSCLC.

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Aude Bandini has received funding from the Arts and Humanities Research Council. Jean-Philippe Drouin-Chartier has received research funding from Dairy Farmers of Canada and the Weston Family ...

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...